Bays, H. E., Rosenson, R. S., Baccara-Dinet, M. T., Louie, M. J., Thompson, D., & Hovingh, G. K. (2018). Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials. Cardiovasc Drugs Ther.

Bays, Harold E., Robert S. Rosenson, Marie T. Baccara-Dinet, Michael J. Louie, Desmond Thompson, a G. Kees Hovingh. "Assessment of the 1% of Patients With Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials." Cardiovasc Drugs Ther 2018.

Bays, Harold E., et al. "Assessment of the 1% of Patients With Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials." Cardiovasc Drugs Ther 2018.